Is a complete BCBA/NVS research report available?

No complete published report is available for bcba/NVS (BCBA/NVS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/NVS (BCBA/NVS)

Buenos Aires Stock Exchange: BCBA/NVS · ARS

ARS 64,750

+225.83 (+0.3%)· Recorded snapshot

Market cap	451.4T
Revenue (ttm)	87.5T
Net income (ttm)	15.3T
EPS (ttm)	ARS 2,022
P/E (trailing)	32.0x
P/E (forward)	16.1x
Dividend	ARS 988 (1.53%)
Volume	182

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 87.5T
Net income (ttm): 15.3T
EPS (ttm): ARS 2,022
P/E (trailing): 32.0x
P/E (forward): 16.1x
Market cap: 451.4T

Metric	Value
Amount currency	ARS
Country	Switzerland
Country code	AR
Earnings date	2026-10-27
Employees	75,267
Employees change	-616
Employees growth	-0.81%
Enterprise value	ARS 513T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT112521
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Last stock split date	2020-10-22
Last stock split type	Forward
Market cap	ARS 451.4T
Next earnings date	2027-02-03
Price	ARS 64,750.00
Price currency	ARS
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bcba/NVS
Website	https://www.novartis.com

Metric

Value

Amount currency

ARS

Country

Switzerland

Country code

Earnings date

2026-10-27

Employees

75,267

Employees change

-616

Employees growth

-0.81%

Enterprise value

ARS 513T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-05-10

Fiscal year end

December

Founded

1996

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

ARDEUT112521

Last earnings date

2026-10-27

Last refreshed

2026-10-28

Last stock split date

2020-10-22

Last stock split type

Forward

Market cap

ARS 451.4T

Next earnings date

2027-02-03

Price

ARS 64,750.00

Price currency

ARS

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-27

Symbol

bcba/NVS

Website

https://www.novartis.com

Metric	Value
Average P/E ratio (10Y)	19.87x
Average P/E ratio (3Y)	17.62x
Average P/E ratio (5Y)	17.8x
Earnings yield	3.12%
EV/Earnings	33.54x
EV/EBIT	17x
EV/EBITDA	13.61x
EV/FCF	21.49x
EV/Sales	5.78x
FCF / EV yield	4.65%
FCF yield	5.29%
Forward P/E	16.08x
Graham number	20138.4654
Graham upside	-68.9%
Lynch fair value	ARS 10,969.61
Lynch upside	-83.06%
P/(FCF - SBC) ratio	20.39x
P/(OCF - SBC) ratio	18.29x
P/B ratio	7.88x
P/E ratio	32.03x
P/FCF ratio	18.91x
P/OCF ratio	17.09x
P/S ratio	5.16x
Price/EBITDA ratio	12.31x

Metric

Value

Average P/E ratio (10Y)

19.87x

Average P/E ratio (3Y)

17.62x

Average P/E ratio (5Y)

17.8x

Earnings yield

3.12%

EV/Earnings

33.54x

EV/EBIT

17x

EV/EBITDA

13.61x

EV/FCF

21.49x

EV/Sales

5.78x

FCF / EV yield

4.65%

FCF yield

5.29%

Forward P/E

16.08x

Graham number

20138.4654

Graham upside

-68.9%

Lynch fair value

ARS 10,969.61

Lynch upside

-83.06%

P/(FCF - SBC) ratio

20.39x

P/(OCF - SBC) ratio

18.29x

P/B ratio

7.88x

P/E ratio

32.03x

P/FCF ratio

18.91x

P/OCF ratio

17.09x

P/S ratio

5.16x

Price/EBITDA ratio

12.31x

Metric	Value
EBIT margin	33.98%
EBITDA margin	41.94%
Effective tax rate	20.8%
FCF margin	27.07%
Gross margin	75.21%
Operating margin	33.98%
Pretax margin	22.04%
Profit margin	17.49%
Profit per employee	ARS 203.2M
Profitable quarters	106
Profitable years	28
Revenue per employee	ARS 1.2B
ROA	10.86%
ROA (5Y)	7.4%
ROCE	23.04%
ROE	24.33%
ROE (5Y)	23.91%
ROIC	19.26%
ROIC (5Y)	17.5%
SBC / revenue	1.98%
Tax / revenue	4.58%

Metric

Value

EBIT margin

33.98%

EBITDA margin

41.94%

Effective tax rate

20.8%

FCF margin

27.07%

Gross margin

75.21%

Operating margin

33.98%

Pretax margin

22.04%

Profit margin

17.49%

Profit per employee

ARS 203.2M

Profitable quarters

106

Profitable years

Revenue per employee

ARS 1.2B

ROA

10.86%

ROA (5Y)

7.4%

ROCE

23.04%

ROE

24.33%

ROE (5Y)

23.91%

ROIC

19.26%

ROIC (5Y)

17.5%

SBC / revenue

1.98%

Tax / revenue

4.58%

Metric	Value
EPS growth	-28.31%
EPS growth (Q)	-68.81%
EPS growth (QoQ)	-63.16%
EPS growth 10Y	6.32%
EPS growth 3Y	12.03%
EPS growth 5Y	3.87%
EPS growth years	1
FCF growth	-20.02%
FCF growth (Q)	-17.79%
FCF growth (QoQ)	-8.09%
FCF growth 3Y	1.3%
FCF growth 5Y	2.63%
Gross profit growth	0.4%
Gross profit growth (Q)	5.89%
Gross profit growth 3Y	8.64%
Gross profit growth 5Y	3.12%
Net income growth	-30.31%
Net income growth (Q)	-69.4%
Net income growth (QoQ)	-63.17%
Net income growth 3Y	8.58%
Net income growth 5Y	0.45%
Net income growth years	1
OCF growth	-17.79%
OCF growth (Q)	-16.25%
OCF growth (QoQ)	-6.44%
OCF growth 10Y	3.71%
OCF growth 3Y	2.64%
OCF growth 5Y	2.66%
Operating income growth	1.26%
Operating income growth (Q)	16.25%
Operating income growth 3Y	19.41%
Operating income growth 5Y	7.48%
Revenue growth	1.76%
Revenue growth (Q)	4.67%
Revenue growth (QoQ)	0.52%
Revenue growth 10Y	1.46%
Revenue growth 3Y	7.75%
Revenue growth 5Y	1.83%
Revenue growth years	3

Metric

Value

EPS growth

-28.31%

EPS growth (Q)

-68.81%

EPS growth (QoQ)

-63.16%

EPS growth 10Y

6.32%

EPS growth 3Y

12.03%

EPS growth 5Y

3.87%

EPS growth years

FCF growth

-20.02%

FCF growth (Q)

-17.79%

FCF growth (QoQ)

-8.09%

FCF growth 3Y

1.3%

FCF growth 5Y

2.63%

Gross profit growth

0.4%

Gross profit growth (Q)

5.89%

Gross profit growth 3Y

8.64%

Gross profit growth 5Y

3.12%

Net income growth

-30.31%

Net income growth (Q)

-69.4%

Net income growth (QoQ)

-63.17%

Net income growth 3Y

8.58%

Net income growth 5Y

0.45%

Net income growth years

OCF growth

-17.79%

OCF growth (Q)

-16.25%

OCF growth (QoQ)

-6.44%

OCF growth 10Y

3.71%

OCF growth 3Y

2.64%

OCF growth 5Y

2.66%

Operating income growth

1.26%

Operating income growth (Q)

16.25%

Operating income growth 3Y

19.41%

Operating income growth 5Y

7.48%

Revenue growth

1.76%

Revenue growth (Q)

4.67%

Revenue growth (QoQ)

0.52%

Revenue growth 10Y

1.46%

Revenue growth 3Y

7.75%

Revenue growth 5Y

1.83%

Revenue growth years

Metric	Value
Capital expenditures	ARS -2.5T
Depreciation and amortization	ARS 7T
EBIT	ARS 29.7T
EBITDA	ARS 36.7T
EPS	ARS 2,021.52
Financing cash flow	ARS 1.2T
Free cash flow	ARS 23.9T
Free cash flow minus SBC	ARS 22.1T
Gross profit	ARS 65.8T
Income taxes	ARS 4T
Investing cash flow	ARS -28.5T
Net borrowing	ARS 24.9T
Net cash flow	ARS -1T
Net income	ARS 15.3T
Operating cash flow minus SBC	ARS 24.7T
Operating income	ARS 29.7T
Revenue	ARS 87.5T
Stock-based compensation	ARS 1.7T

Metric

Value

Capital expenditures

ARS -2.5T

Depreciation and amortization

ARS 7T

EBIT

ARS 29.7T

EBITDA

ARS 36.7T

EPS

ARS 2,021.52

Financing cash flow

ARS 1.2T

Free cash flow

ARS 23.9T

Free cash flow minus SBC

ARS 22.1T

Gross profit

ARS 65.8T

Income taxes

ARS 4T

Investing cash flow

ARS -28.5T

Net borrowing

ARS 24.9T

Net cash flow

ARS -1T

Net income

ARS 15.3T

Operating cash flow minus SBC

ARS 24.7T

Operating income

ARS 29.7T

Revenue

ARS 87.5T

Stock-based compensation

ARS 1.7T

Metric	Value
Altman Z-Score	3.56
Book value per share	ARS 30,058.39
Debt / EBITDA	1.98
Debt / equity	1.29
Debt / FCF	3.09
Goodwill	ARS 41.8T
Interest coverage	12.36
Long-term assets	ARS 134.4T
Long-term liabilities	ARS 71.4T
Net cash (debt)	ARS -60.1T
Net cash / market cap	-13.32%
Net debt / EBITDA	1.64
Net debt / equity	1.05
Net debt / FCF	2.52
Piotroski F-Score	5
Property, plant and equipment	ARS 18.9T
Shareholders' equity	ARS 57.3T
Tangible book value	ARS -45.4T
Tangible book value per share	ARS -24,039.93
Total assets	ARS 178.6T
Total cash	ARS 13.5T
Total debt	ARS 73.7T
Total liabilities	ARS 121.4T

Metric

Value

Altman Z-Score

3.56

Book value per share

ARS 30,058.39

Debt / EBITDA

1.98

Debt / equity

1.29

Debt / FCF

3.09

Goodwill

ARS 41.8T

Interest coverage

12.36

Long-term assets

ARS 134.4T

Long-term liabilities

ARS 71.4T

Net cash (debt)

ARS -60.1T

Net cash / market cap

-13.32%

Net debt / EBITDA

1.64

Net debt / equity

1.05

Net debt / FCF

2.52

Piotroski F-Score

Property, plant and equipment

ARS 18.9T

Shareholders' equity

ARS 57.3T

Tangible book value

ARS -45.4T

Tangible book value per share

ARS -24,039.93

Total assets

ARS 178.6T

Total cash

ARS 13.5T

Total debt

ARS 73.7T

Total liabilities

ARS 121.4T

Metric	Value
Asset turnover	0.51
Current assets	ARS 44.2T
Current liabilities	ARS 50T
Current ratio	0.88
Inventory turnover	2.27
Net working capital	ARS -4.2T
Quick ratio	0.58
Working capital	ARS -5.8T
Working capital turnover	-23,080.31

Metric

Value

Asset turnover

0.51

Current assets

ARS 44.2T

Current liabilities

ARS 50T

Current ratio

0.88

Inventory turnover

2.27

Net working capital

ARS -4.2T

Quick ratio

0.58

Working capital

ARS -5.8T

Working capital turnover

-23,080.31

Metric	Value
Buyback yield / dilution	2.76%
Dividend growth	58.23%
Dividend growth (10Y)	34.36%
Dividend growth (3Y)	28.65%
Dividend growth (5Y)	80.51%
Dividend growth years	3
Dividend payment date	2026-03-16
Dividend payment years	3
Dividend payout frequency	Annual
Dividend per share	ARS 988.41
Dividend yield	1.53%
Ex-dividend date	2026-03-11
Last dividend	ARS 988.41
Payout ratio	90.4%
Shareholder yield	4.29%

Metric

Value

Buyback yield / dilution

2.76%

Dividend growth

58.23%

Dividend growth (10Y)

34.36%

Dividend growth (3Y)

28.65%

Dividend growth (5Y)

80.51%

Dividend growth years

Dividend payment date

2026-03-16

Dividend payment years

Dividend payout frequency

Annual

Dividend per share

ARS 988.41

Dividend yield

1.53%

Ex-dividend date

2026-03-11

Last dividend

ARS 988.41

Payout ratio

90.4%

Shareholder yield

4.29%

Metric	Value
150-day SMA	ARS 58,284.83
1D price change	0.35%
1M price change	10.12%
1M total return	10.12%
1W price change	6.37%
1W total return	6.37%
1Y price change	26.9%
1Y return CAGR	29.08%
1Y total return	29.05%
20-day SMA	ARS 59,853.75
200-day SMA	ARS 58,066.00
3M price change	4.86%
3M total return	4.86%
3Y price change	215.85%
3Y return CAGR	49.33%
3Y total return	233.1%
50-day SMA	ARS 59,726.00
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 67,200.00
52-week high date	2026-07-03
52-week low	ARS 43,680.00
52-week low date	2025-10-27
5Y price change	1,430.73%
5Y return CAGR	74.87%
5Y total return	1,534.36%
6M price change	19.08%
6M total return	19.08%
All-time high	ARS 67,200.00
All-time high date	2026-07-03
All-time low	ARS 1,961.00
All-time low date	2020-01-27
Average true range (ATR)	ARS 1,247.21
Average volume	512.6
Change from 52-week high	-3.65%
Change from 52-week low	48.24%
Change from all-time high	-3.65%
Change from all-time low	3,201.89%
Change from open	0.04%
Day's gap	0.31%
Dollar volume	ARS 11.8M
High price	ARS 65,025.00
Low price	ARS 64,450.00
Monthly RSI	71.9
Open price	ARS 64,725.00
Position in 52-week range	52.17%
Previous close	ARS 64,525.00
Price vs 150-day SMA	11.09%
Price vs 20-day SMA	8.18%
Price vs 200-day SMA	11.51%
Price vs 50-day SMA	8.41%
Relative volume	0.36
RSI	69.63
Sharpe ratio	0.98
Sharpe ratio (3Y)	1.22
Sharpe ratio (5Y)	1.67
Sortino ratio	1.51
Sortino ratio (3Y)	1.97
Sortino ratio (5Y)	2.77
Volume	182
Weekly RSI	59.64
YTD price change	22%
YTD total return	24.07%

Metric

Value

150-day SMA

ARS 58,284.83

1D price change

0.35%

1M price change

10.12%

1M total return

10.12%

1W price change

6.37%

1W total return

6.37%

1Y price change

26.9%

1Y return CAGR

29.08%

1Y total return

29.05%

20-day SMA

ARS 59,853.75

200-day SMA

ARS 58,066.00

3M price change

4.86%

3M total return

4.86%

3Y price change

215.85%

3Y return CAGR

49.33%

3Y total return

233.1%

50-day SMA

ARS 59,726.00

50-day SMA vs 200-day SMA

50over200

52-week high

ARS 67,200.00

52-week high date

2026-07-03

52-week low

ARS 43,680.00

52-week low date

2025-10-27

5Y price change

1,430.73%

5Y return CAGR

74.87%

5Y total return

1,534.36%

6M price change

19.08%

6M total return

19.08%

All-time high

ARS 67,200.00

All-time high date

2026-07-03

All-time low

ARS 1,961.00

All-time low date

2020-01-27

Average true range (ATR)

ARS 1,247.21

Average volume

512.6

Change from 52-week high

-3.65%

Change from 52-week low

48.24%

Change from all-time high

-3.65%

Change from all-time low

3,201.89%

Change from open

0.04%

Day's gap

0.31%

Dollar volume

ARS 11.8M

High price

ARS 65,025.00

Low price

ARS 64,450.00

Monthly RSI

71.9

Open price

ARS 64,725.00

Position in 52-week range

52.17%

Previous close

ARS 64,525.00

Price vs 150-day SMA

11.09%

Price vs 20-day SMA

8.18%

Price vs 200-day SMA

11.51%

Price vs 50-day SMA

8.41%

Relative volume

0.36

RSI

69.63

Sharpe ratio

0.98

Sharpe ratio (3Y)

1.22

Sharpe ratio (5Y)

1.67

Sortino ratio

1.51

Sortino ratio (3Y)

1.97

Sortino ratio (5Y)

2.77

Volume

182

Weekly RSI

59.64

YTD price change

22%

YTD total return

24.07%

Metric	Value
Float	1.9B
Shares change (QoQ)	-0.47%
Shares change (YoY)	-2.76%
Shares held by insiders	0.11%
Shares held by institutions	36.29%

Metric

Value

Float

1.9B

Shares change (QoQ)

-0.47%

Shares change (YoY)

-2.76%

Shares held by insiders

0.11%

Shares held by institutions

36.29%

BCBA/NVS (BCBA/NVS)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/NVS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/NVS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/NVS

Frequently asked questions